Systemische therapie maligner nebennierentumoren

Translated title of the contribution: Systemic therapy of malignant adrenal tumors

M. Horstmann, A. S. Merseburger, Arnulf Stenzl, M. Kuczyk*

*Corresponding author for this work
1 Citation (Scopus)


Systemic treatment of advanced-stage adrenal malignancies is most often only palliative. Mitotane alone or in combination with other chemotherapeutic agents such as cisplatin, etoposide, and vincristine are established therapeutic concepts for the treatment of metastatic adrenal cancer. Suramin and gossypol are rarely employed. New therapeutic options are tumor vaccination and treatment with antiangiogenic drugs. Metaiodobenzylguanidine as a radiotherapeutic drug or chemotherapeutic combination therapies that include cyclophosphamide, vincristine, and dacarbazine are applied for systemic treatment of malignant pheochromocytomas.. However, the clinical efficacy of the latter regimen needs further evaluation.

Translated title of the contributionSystemic therapy of malignant adrenal tumors
Original languageGerman
JournalUrologe - Ausgabe A
Issue number5
Pages (from-to)605-608
Number of pages4
Publication statusPublished - 05.2006

Research Areas and Centers

  • Research Area: Luebeck Integrated Oncology Network (LION)


Dive into the research topics of 'Systemic therapy of malignant adrenal tumors'. Together they form a unique fingerprint.

Cite this